Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation-Reference-Cited by-同舟云学术

Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation

Published:2021-09 Issue:9 Volume:38 Page:1563-1583
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Doshi Nidhi^ORCID,Ritchie Kyle,Shobha Tamanna,Giddings Jamie,Gregoritza Kathrin,Taing Rosalynn,Rumbelow Stephen,Chu Jeff,Tomlinson Anthony,Kannan Aadithya,Saggu Miguel,Cai Si Kai,Nicoulin Victor,Liu Wenqiang,Russell Steve,Luis Lin,Yadav Sandeep

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-021-03087-9.pdf

Reference69 articles.

1. Bam NB, Cleland JL, Yang J, Manning MC, Carpenter JF, Kelley RF, et al. Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. J Pharm Sci. 1998;87(12):1554–9.

2. Kerwin BA. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci. 2008;97(8):2924–35.

3. Mahler HC, Printz M, Kopf R, Schuller R, Muller R. Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques. J Pharm Sci. 2008;97(2):764–74.

4. Mahler H-C, Huber F, Kishore RS, Reindl J, Rückert P, Müller R. Adsorption behavior of a surfactant and a monoclonal antibody to sterilizing-grade filters. J Pharm Sci. 2010;99(6):2620–7.

5. United States Pharmacopeial Convention. United States Pharmacopeia and national formulary. Rockville, MD: United States Pharmacopeial Convention; 2018.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations;European Journal of Pharmaceutics and Biopharmaceutics;2024-01

2. Oxidation of polysorbates – An underestimated degradation pathway?;International Journal of Pharmaceutics: X;2023-12

3. The ice age – A review on formulation of Adeno-associated virus therapeutics;European Journal of Pharmaceutics and Biopharmaceutics;2023-09

4. Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers;Journal of Pharmaceutical and Biomedical Analysis;2023-09

5. Development of UPLC-UV-ELSD Method for Fatty Acid Profiling in Polysorbate 80 and Confirmation of the Presence of Conjugated Fatty Acids by Mass Spectrometry, UV Absorbance and Proton Nuclear Magnetic Resonance Spectroscopy;Journal of Pharmaceutical Sciences;2023-09